Skip to search formSkip to main contentSkip to account menu

ONO 6818

Known as: ONO-6818 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

OxadiazolesPyrimidinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Neutrophil elastase in colitis: more than a marker of disease activity?
studied its functional role on epithelial cell proliferation, and reported that NE in organ culture supernatants from UC patients… 
2005
2005
Pathophysiological studies of trinitrobenzene sulfonic acid-induced colitis in Syrian hamsters (Mesocricetus auratus).
We developed a colitis model in Syrian hamsters (Mesocricetus auratus) to investigate the relationship between colitis and… 
2005
2005
ONO-6818, a novel, potent neutrophil elastase inhibitor, reduces inflammatory mediators during simulated extracorporeal circulation
2004
2004
Effects of the neutrophil elastase inhibitor (ONO-6818) on acetic acid induced colitis in Syrian hamsters.
Neutrophil elastase (NE) released from neutrophils during inflammation is related to tissue disturbance and organ failure. We… 
2004
2004
1064-178 A novel oral neutrophil elastase inhibitor, ONO-6818, suppressed early atherosclerotic plaque formation in apolipoprotein E-knockout mice
Review
2002
Review
2002
ONO-6818 Cortech/Ono.
ONO-6818 (CP-955) is the lead compound in a series of orally bioavailable neutrophil elastase inhibitors licensed from Cortech… 
2001
2001
A novel oral neutrophil elastase inhibitor (ONO-6818) inhibits human neutrophil elastase-induced emphysema in rats
2001
2001
Design and synthesis of new orally active inhibitors of human neutrophil elastase.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)